MedTrace Logo

Oral Caffeine and Spinal-Induced Hypotension

NCT07076654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-18

No results posted yet for this study

Summary

Hypotension after spinal anesthesia is critical. Thus several interventions have been proposed to mitigate such effect.

Conditions

  • Spinal Hypotension
  • Caffeine

Interventions

DRUG

Caffeine (200 mg)

Oral caffeine will be given as 200 mg before spinal anesthesia

DRUG

Placebo

Patient at this arm will receive placebo

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-12
Primary Completion
2025-10-01
Completion
2025-10-02

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07076654 on ClinicalTrials.gov